Handelsbanken Fonder AB VERA — VERA THERAPEUTICS INC CL A

Ownership history in Handelsbanken Fonder AB  ·  9 quarters on record

AI Ownership Summary

Handelsbanken Fonder AB reported VERA THERAPEUTICS INC CL A (VERA) in 9 quarterly 13F filings from 2024 Q2 through 2026 Q2. The latest visible filing shows VERA at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this VERA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Handelsbanken Fonder AB's position in VERA THERAPEUTICS INC CL A, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

VERA was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Handelsbanken Fonder AB held VERA — position size vs. price
% of Fund (quarterly)    VERA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED — — — 22,100 +2,300 +11.6% 0.00% $948 2026-07-10 $42.00
2026 Q1 UNCHANGED — — — 19,800 — 0% 0.00% $797 2026-04-28 $37.11
2025 Q4 REDUCED 7.9% -20.6% ✅ 19,800 -1,700 -7.9% 0.00% $1.0M 2026-02-06 $43.50
2025 Q3 ADDED — — — 21,500 +4,900 +29.5% 0.00% $625K 2025-11-12 $31.08
2025 Q2 ADDED — — — 16,600 +2,800 +20.3% 0.00% $391K 2025-08-12 $21.14
2025 Q1 UNCHANGED — — — 13,800 — 0% 0.00% $331K 2025-04-15 $21.59
2024 Q4 UNCHANGED — — — 13,800 — 0% 0.00% $584K 2025-02-03 $36.54
2024 Q3 ADDED — — — 13,800 +2,200 +19.0% 0.00% $610K 2024-10-04 $40.84
2024 Q2 INITIATED — — — 11,600 — — 0.00% $420K 2024-08-05 $36.00

FAQ About Handelsbanken Fonder AB and VERA

These are the practical questions this page is built to answer before you even open the full history table.

How long has Handelsbanken Fonder AB reported owning VERA?

Handelsbanken Fonder AB reported VERA across 9 quarterly 13F filings, from 2024 Q2 through 2026 Q2.

What was the largest reported VERA position in Handelsbanken Fonder AB's portfolio?

The largest reported portfolio weight for VERA was 0.00% in 2025 Q4.

What is the latest reported VERA position on this page?

The most recent filing on this page is 2026 Q2, when Handelsbanken Fonder AB reported 22,100 shares, equal to 0.00% of portfolio, with an estimated market value of $948.

What does the chart on this VERA ownership page compare?

The chart compares Handelsbanken Fonder AB's quarterly VERA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Handelsbanken Fonder AB time their VERA position?

Based on 13F filing dates vs. subsequent VERA price moves, Handelsbanken Fonder AB correctly timed 4 out of 5 reported position changes (80%). The annualised alpha on VERA relative to SPY over the holding period was +351.7%.

← Back to Handelsbanken Fonder AB Holdings